Purine L-nucleosides, analogs and uses thereof
US6509320B1 · kind B1 · utility
55Cited by
11References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2000 |
| Grant date | Jan 21, 2003 |
| Priority date | — |
| Expiry date | Oct 6, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel purine L-nucleoside compounds are disclosed, in which both the purine rings and the sugar are either modified, functionalized or both. The novel compounds or pharmaceutically acceptable esters or salts thereof may be used in pharmaceutical compositions, and such compositions may be used to treat an infection, an infestation, a neoplasm, or an autoimmune disease. The novel compounds may also be used to modulate aspects of the immune system, including modulation of Th1 and Th2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.